As global leaders in the field of RNA-based therapeutics, we are aggressively leveraging our differentiated and proprietary RNA-based antisense platforms to discover and advance innovative therapeutic candidates. read more >

We are committed to the discovery and development of novel RNA-based therapeutics providing patients transformative treatment options. Our programs target rare diseases and infectious diseases. read more >

Our novel RNA-based platforms are highly differentiated, offering an opportunity to target a range of diseases and disorders via utilization of proprietary advanced chemistries and distinct mechanisms of action. read more >